Intentionale Wissenschaft,
Medi First R&D is the research and development unit within the Medi First Group. We work where scientific insights must become clinically actionable - at the interface of pharmacological potential, formulation precision, and clinical responsibility. Our focus is cannabinoid-based phytomedicine, aligned with clear target profiles (TPP), robust evidence pathways, and a development logic that makes safety and traceability the benchmark.
We believe in the right to the best possible, evidence-based care. Our mission is not to produce science, but to translate it into care that protects quality of life and enables autonomy. For us, intentional science means that research is never an end in itself. It is a mandate to patients, professional communities, and institutions to make benefits and risks understandable, justifiable, and verifiable.
The MediFirst principle: the right to evidence
Everyone has the right to treatment whose benefits and risks are transparent. That is why we align development with internationally compatible quality standards and understand research as a tool for safety. Insights are translated into documented development logic so that clinical decisions can rest on a professional foundation.
The person behind the finding
Behind every finding is a life story. Chronic conditions are often a gradual erosion of self-determination and everyday life. That is why we look not only at symptoms, but at the person in context. Our work follows a precise, indication-specific perspective. We develop profiles aligned with clinical requirements and place insights into the endocannabinoid system (ECS) in an evidence-based framework in order to better understand regulatory processes and shape therapy profiles responsibly.
We understand medical excellence as service to the community.
When people lose their ability to act due to illness, it is a loss for them, their surroundings, and society. Our mission is reintegration. We want to help people participate again - at work, in social life, and in their autonomy. By promoting comparability, standardization, and robust evidence, we support informed decisions and help reduce under- and over-treatment. Humanity and economic reason are not opposites; they depend on each other when lasting value is to be created.
In the end, this is the consequence of everything we do. Evidence is not an after-the-fact proof, but part of development. Patient-centeredness is not a headline, but a structure. Integrity is not a formality, but a prerequisite - in data protection, data quality, and responsible implementation.
Scientific LeadershipMedi First Group
